These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7330548)

  • 1. [Results of short course anti-tuberculous treatment (author's transl)].
    Yáñez A; Valenzuela P
    Rev Med Chil; 1981 Jul; 109(7):695-9. PubMed ID: 7330548
    [No Abstract]   [Full Text] [Related]  

  • 2. [A five year follow-up study of antituberculosis chemotherapy with and without rifampicin (author's transl)].
    Matsumiya T; Yoshida F; Inoue M; Yoshimura M; Ogawa T; Yoshida R; Ishii A
    Kekkaku; 1980 Feb; 55(2):43-51. PubMed ID: 7373965
    [No Abstract]   [Full Text] [Related]  

  • 3. [Intermittent rifampicine treatment of experimental tuberculosis. Morpho-pathological study (author's transl)].
    Diaconitza G; Lutzesco L
    Acta Tuberc Pneumol Belg; 1974; 65(2):228-42. PubMed ID: 4213882
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical trials on chemotherapy of tuberculosis in Chile (author's transl)].
    Farga V
    Rev Med Chil; 1981 Aug; 109(8):769-73. PubMed ID: 7043693
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical study on rifampicin applied every other day for severe cavitary pulmonary tuberculosis (author's transl)].
    Kitatani F; Fujimoto S; Asahi T; Konishiike J; Sera Y
    Kekkaku; 1974 May; 49(5):133-8. PubMed ID: 4408937
    [No Abstract]   [Full Text] [Related]  

  • 6. [Three-year follow-up results of the first clinical study on the daily and twice-weekly administrations of rifampicin, investigated by the Tuberculosis Research Committee, Ryoken (author's transl)].
    Kekkaku; 1974 Apr; 49(4):107-12. PubMed ID: 4411274
    [No Abstract]   [Full Text] [Related]  

  • 7. The comparison of tuberculosis treatments: a short course therapy and the directly observed short course treatment (DOTS), East Java Province, Indonesia.
    Roosihermiatie B; Nishiyama M; Nakae K
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):85-8. PubMed ID: 11023071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Histological observation on the tuberculous lesions aggravated during rifampicin treatment (author's transl)].
    Iwai K; Kino C; Tsuchiya S; Kita R; Kinoshita T
    Kekkaku; 1979 Sep; 54(9):473-8. PubMed ID: 502155
    [No Abstract]   [Full Text] [Related]  

  • 9. [Short-course chemotherapy for pulmonary tuberculosis. 2. Evaluation of short-course chemotherapy in experimental murine tuberculosis (author's transl)].
    Oda T
    Kekkaku; 1981 Jan; 56(1):17-21. PubMed ID: 7230589
    [No Abstract]   [Full Text] [Related]  

  • 10. [Problems in treatment of pulmonary tuberculosis: in terms of bacteriologic relapse (author's transl)].
    Mochizuki K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1980 Sep; 18(9):597-604. PubMed ID: 7289249
    [No Abstract]   [Full Text] [Related]  

  • 11. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A follow-up study on cases treated with daily and intermittent regimens of rifampicin (author's transl)].
    Yamamoto K; Aizawa H; Ochi T; Kawamori Y; Kakuno J
    Kekkaku; 1974 Sep; 49(9):289-93. PubMed ID: 4444092
    [No Abstract]   [Full Text] [Related]  

  • 13. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of the effects between combined chemotherapy with and without rifampicin in original and re-treatment of pllmonary tuberculosis, with special reference to the grade of improvement of chest x-ray findings (author's transl)].
    Yoshida F; Inoue M; Yoshimura M; Ogawa T; Yoshida R
    Kekkaku; 1976 Sep; 51(9):353-62. PubMed ID: 1003722
    [No Abstract]   [Full Text] [Related]  

  • 15. [Aggravation and relapse of tuberculosis before and after the clinical application of rifampicin (author's transl)].
    Shimizu T
    Kekkaku; 1976 Dec; 51(12):507-8. PubMed ID: 1018407
    [No Abstract]   [Full Text] [Related]  

  • 16. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
    Khodashova ML; Iuditskiĭ MV; Semenova OV
    Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-course chemotherapy for paediatric respiratory tuberculosis: 5-year report.
    Swaminathan S; Raghavan A; Duraipandian M; Kripasankar AS; Ramachandran P
    Int J Tuberc Lung Dis; 2005 Jun; 9(6):693-6. PubMed ID: 15971400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Corticosteroids in the treatment of cavitating pulmonary tuberculosis (author's transl)].
    Saatçi H; Meral N
    Prax Klin Pneumol; 1980 Jan; 34(1):42-4. PubMed ID: 7367380
    [No Abstract]   [Full Text] [Related]  

  • 19. [A case of small-cell carcinoma misdiagnosed as lung tuberculosis in consequence of shadow regression during initial administration of rifampicin (author's transl)].
    Hirata S
    Kekkaku; 1981 May; 56(5):275-80. PubMed ID: 6273641
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical notes on rifampin--a new antituberculosis drug.
    Raleigh JW
    Clin Notes Respir Dis; 1972; 11(1):3-11. PubMed ID: 5033323
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.